Knee Segment Held Largest Share of Cartilage Degeneration Market in 2019

According to our new market research study on “North America Cartilage Degeneration Market Forecast to 2027 – COVID-19 Impact and Analysis – by Procedure Type, Application, and End User,” the market is expected to reach US$ 6,998.45 million by 2027 from US$ 4,889.27 million in 2019; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. The report provides trends prevailing in the North America cartilage degeneration market and the factors driving the market growth along with those hindering it.

Based on application, the knee segment accounted for the largest share of the market in 2019. The growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to a study published in an online newspaper, one in four adults in this region suffer from chronic knee pain. Furthermore, the increasing awareness of benefits provided by cartilage repair is anticipated to drive the growth of the knee segment in North America.

The growth of the North America cartilage degeneration market is mainly attributed to growing number of sports injuries and increasing prevalence of obesity. However, the high cost of cartilage repair therapies is restricting the market growth.

Zimmer Biomet; Stryker Corporation; Johnson and Johnson Services, Inc.; CONMED Corporation; Arthrex, Inc; and Anika Therapeutics, Inc are among the leading companies operating in the North America cartilage degeneration market.

North America Cartilage Degeneration Market, By Country, 2019 (%)

The report segments North America cartilage degeneration market as follows:

By Procedure Type

• Joint Replacement
• Chondroplasty
• Cell-based Cartilage Resurfacing
• Osteochondral Transplant
• Meniscus Transplants
• Others

By Application

• Knee
• Hips
• Others

By End User

• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Academic & Research Institutes

By Country

• US
• Canada
• Mexico